| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |